Paratek Pharmaceuticals Competitors and Similar CompaniesClear all
Paradigm Diagnostics's competitors and similar companies include Cipla and Keros Therapeutics.
 Paradigm Diagnostics Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. | |
Founding Date | Founding Date 2012 | Founding Date 1935 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Phoenix, US HQ | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Lexington, US HQ South Wharf, AU |
Employees | Employees 717% increase | Employees 27,764 | Employees 7854% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) $244.1m (FY, 2025) |
Net income | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income $87m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 23.9m | Total funding raised N/A | Total funding raised $ 90m |
For sources of this data, please see the company profile
View Company Profiles
Cipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyKeros Therapeutics
HQ
Lexington, US
Employees
78
Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View company